Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,403,688 | 1,367,907 | 1,425,059 | 1,384,419 | 1,536,222 |
| Marketable Securities | 1,687,257 | 1,646,284 | 1,651,617 | 1,588,220 | 1,361,316 |
| Receivables | 554,268 | 480,600 | 540,622 | 509,265 | 393,741 |
| Other current assets | 0 | -1 | 0 | 0 | -1 |
| TOTAL | $3,645,213 | $3,494,790 | $3,617,298 | $3,481,904 | $3,291,278 |
| Non-Current Assets | |||||
| PPE Net | 97,812 | 95,306 | 98,801 | 92,464 | 86,724 |
| Investments And Advances | 28,743 | 36,041 | 59,026 | 93,098 | 122,061 |
| Intangibles | 30,888 | 35,287 | 40,411 | 43,615 | 48,144 |
| Other Non-Current Assets | 126,412 | 95,607 | 102,620 | 92,940 | 96,287 |
| TOTAL | $283,855 | $262,241 | $300,858 | $322,117 | $353,216 |
| Total Assets | $3,929,068 | $3,757,031 | $3,918,156 | $3,804,021 | $3,644,494 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 225,225 | 188,952 | 235,468 | 201,739 | 175,068 |
| Other current liabilities | 858 | N/A | N/A | N/A | N/A |
| TOTAL | $277,992 | $201,921 | $249,469 | $290,238 | $218,997 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,718 | 3,921 | 4,137 | 4,124 | 4,215 |
| Other Non-Current Liabilities | 80,509 | 55,645 | 59,822 | 60,744 | 63,705 |
| TOTAL | $150,150 | $129,085 | $137,303 | $137,982 | $142,648 |
| Total Liabilities | $428,142 | $331,006 | $386,772 | $428,220 | $361,645 |
| Shareholders' Equity | |||||
| Common Shares | 9,438 | 9,953 | 10,501 | 10,468 | 10,699 |
| Retained earnings | 1,750,749 | 1,585,210 | 1,594,182 | 1,449,445 | 1,323,384 |
| Other shareholders' equity | 15,730 | 14,627 | 12,887 | 13,322 | 13,292 |
| TOTAL | $3,500,926 | $3,426,025 | $3,531,384 | $3,375,801 | $3,282,849 |
| Total Liabilities And Equity | $3,929,068 | $3,757,031 | $3,918,156 | $3,804,021 | $3,644,494 |